Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Zero based budgeting yields tangible outcomes compared to traditional budgeting, including tighter control and clearer allocation of resources.
22,247 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Micron’s latest earnings and bold capex plans intensify the debate over whether the memory giant can achieve a trilli...
Stocks hover near record levels while consumer sentiment sinks to multi-decade lows. This piece examines trump’s bull...
SpaceX is pursuing a landmark IPO with a $1.75 trillion target, a level that demands extraordinary growth. Experts ou...
When a tech icon hints at a trillion-dollar future, investors listen. This article breaks down the math, the bets, an...
A bitcoin miners ETF posted a dramatic weekly surge, underscoring how mining infrastructure can deliver cash flows ev...
Want a steady income stream without guessing individual stocks? Learn about three dividend ETFs built long-term that ...
shark tank’s kevin o’leary identifies two booming opportunities in AI for 2026: helping small businesses deploy AI to...
Circle Internet Group stock has tumbled amid regulatory whispers around stablecoins. This guide breaks down what the ...
U.S. title insurers posted stronger Q1 2026 results, led by a rebound in commercial activity and gains from automatio...
A director sale can grab attention, but IPG Photonics is quietly reshaping its core business. Here’s how the brand is...
Stocks slid Friday as investors weighed whether AI-driven growth can sustain lofty valuations. Analysts warn this cou...